Gene and protein expressions in human cord blood cells after exposure to acrylonitrile

Journal of Biochemical and Molecular Toxicology

Volumn 19, Issue 4, 2005, Pages 204-212

  Diodovich, Cristina ^a,c   Malerba, Ilaria ^a,c   Ferrario, Daniele ^a   Bowe, Gerard ^b   Bianchi, Marco Giorgio ^b   Acquati, Francesco ^b   Taramelli, Roberto ^b   Parent Massin, Dominique ^c   Gribaldo, Laura ^a  

^a JOINT RESEARCH CENTRE   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

Acrylonitrile; Cord Blood Cells; Gene Expression; Macroarray; Protein Expression

Indexed keywords

ACRYLONITRILE; CALGRANULIN; CARCINOGEN; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; CYTOKINE RECEPTOR; INDUSTRIAL CHEMICAL; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C FOS; RNA; STRESS ACTIVATED PROTEIN KINASE;

ACUTE TOXICITY; APOPTOSIS; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL ASSAY; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL HYBRIDIZATION; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE FUNCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

ACRYLONITRILE; CARCINOGENS; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; FETAL BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 24944546616     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20090     Document Type: Article

References (22)

1. Maltoni C, Ciliberti A, Di Maio V. Carcinogenicity bioassays on rats of ACN administered by inhalation and by ingestion. Med Lav 1977;68:401-411.
2. Léonard A, Gerber GB, Stecca C, Rueff J, Borba H, Farmer PB, Sram RJ, Czeizel AE, Kalina I. Mutagenicity, carcinogenicity, and teratogenicity of ACN. Mutat Res 1999;436:263-283.
3. IARC International Agency for Research on Cancer reevaluation of some organic chemicals, Hydrazine and hydrogen peroxide. In: IARC monographs on the evaluation of carcinogenic risks to humans; 1999;71, pp 43-108.
4. Their R, Lewalter J, Bolt HM. Species differences in acry-lonitrile metabolism and toxicity between experimental animals and humans based on observations in human accidental poisonings. Arch Toxicol 2000;74:184-189.
5. Schettgen T, Kutting B, Hornig M, Beckmann MW, Weiss T, Drexler H, Angerer J. Trans-placental exposure of neonates to acrylamide-a pilot study. Int Arch Occup Environ Health 2004; 22 (Epub ahead of print).
6. Felter SP, Dollarhide JS. Acrylonitrile: A re-evaluation of the database to support an inhalation cancer risk assessment. Regul Toxicol Pharmacol 1997;26(3):281-287.
7. Whysner J, Steward RE III, Chen D, Conaway CC, Verna LK, Richie JP Jr, Ali N, Williams GM. Formation of 8-oxodeoxyguanosine in brain DNA of rats exposed to acrylonitrile. Arch Toxicol 1998;72(7):429-438.
8. Diodovich C, Malerba I, Bowe G, Acquati F, Bianchi MG, Taramelli R, Parent-Massin D, Gribaldo L. Naphthalene exposure: Effects on gene expression and proliferation in human cord blood cells. J Biochem Mol Toxicol 2003;17(5):286-294.
9. EU risk assessment report acrylonitrile, 2001.
10. Pessina A, Albella B, Bueren J, Brantom P, Casati S, Gribaldo L. Croera C, Gagliardi G, Foti P, Parchment R, Parent-Massin D, Sibiril Y, Van Den Heuvel R. Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol Vitr 2001;15:729-740.
11. Jacob S, Ahmed AE. Effect of route of administration on the disposition of acrylonitrile: Quantitative wholebody autoradiographic study in rats. Pharmacol Res 2003;48(5):479-488.
12. Mantovani A. The chemokine system: Redundancy for robust outputs. Immunol Today 1999;20(6): 254-257.
13. Conti I, Dube C, Rollins BJ. Chemokine-based pathogenetic mechanisms in cancer. Novartis Found Symp 2004;256:29-41.
14. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ. Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96(1):34-40.
15. Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, Henderson R, Robinson MJ, Hogg N. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 2003;23(7):2564-2576.
16. Lataillade JJ, Clay D, Bourin P, Herodin F, Dupuy C, Jasmin C, Bousse-Kerdiles MC. Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: Evidence for an autocrine/paracrine mechanism. Blood 2002;99(4):1117-1129.
17. Hernandez-Lopez C, Varas A, Sacedon R, Jimenez E, Munoz JJ, Zapata AG, Vicente A. Stromal cell-derived factor 1/CXCR4 signaling is critical for early human T-cell development. Blood 2002;99(2):546-554.
18. Gorbunov NV, Morris JE, Greenberger JS, Thrall BD. Establishment of a novel clonal murine bone marrow stromal cell line for assessment of p53 responses to genotoxic stress. Toxicology 2002;179(3):257-266.
19. Hsu YL, Kuo PL, Chiang LC, Lin CC. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines. Cancer Lett 2004;213(2):213-221.
20. Diodovich C, Bianchi MG, Bowe G, Acquati F, Taramelli R, Parent-Massin D, Gribaldo L. Response of human cord blood cells to styrene exposure: Evaluation of its effects on apoptosis and gene expression by genomic technology. Toxicology 2004;200:145-157.
21. Fu W, Begley JC, Killen MW, Mattson MP. Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 1999;274:7264-7271.
22. Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E. Retinoids downregulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc Natl Acad Sci USA 2001;98:6662-6667.